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Summary The Hospital Anxiety and Depression (HAD) scale, a self-report questionnaire, was tested as a
method of identifying mood disorder among patients with operable breast cancer during the year after
diagnosis. In a cohort of 91 patients anxiety and depression were assessed preoperatively, and at 3 and 12
months post-operatively, using a standardised psychiatric interview and diagnostic rating criteria. The patients
also completed the HAD scale at each assessment. Fifty out of 91 (55%) patients were full or borderline cases
of depression and/or anxiety at one or more assessment points. Using a receiver operator characteristic curve
analysis, the optimum threshold for the preoperative HAD scale total score to identify psychiatric disorder
either preoperatively or at 3 and 12 months post-operatively was 11. With this threshold 70% of both full and
borderline cases occurring at any of the assessment points were correctly identified. The false-positive rate was
12%. This approach was particularly sensitive to full cases, correctly identifying 90% of them. The potential
for the preoperative HAD scale total score to identify mood disorder in the year after diagnosis was influenced
by age. Among women aged less than 50 years, a preoperative HAD scale total score > 11 provided a highly
sensitive indicator of mood disorder (full and borderline cases) at any time in the year after diagnosis
(sensitivity = 90%). The false-positive rate was 40%. Among women older than 50 who experienced a mood
disorder, only 57% were correctly identified by a HAD scale total score of > 11 (sensitivity = 57%). However,
the false-positive rate among older women was low (3%). This simple preoperative screening approach can be
used to identify patients who have or are at high risk of developing severe mood disorder in the year after
diagnosis. The HAD scale is also sensitive to the detection of borderline mood disorder in patients under the
age of 50. It is a specific screening tool among patients over 50, but is not sensitive to the detection of
borderline mood disorder in this age group.
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About 25% of patients with early breast cancer experience
anxiety and depression at any one time in the year after
diagnosis (Dean, 1987; Fallowfield et al., 1990). This includes
depressive illnesses and anxiety states as well as borderline
mood disorders. During routine medical care only 20-50%
of these distressed patients are recognised and referred for
appropriate help (Maguire, 1984a). This identification rate
might be increased by improving the communication skills
and psychiatric interview techniques of cancer professionals
(Maguire, 1984b).
An alternative approach involves screening for mood
disorder by asking patients to complete self-report question-
naires at regular intervals. The effectiveness of the Hospital
Anxiety and Depression (HAD) scale (Zigmond and Snaith,
1983) in detecting already existing mood disorder has been
assessed in a number of different cancer populations (Razavi
et al., 1990, 1992; Hopwood et al., 1991; Ibbotson et al.,
1994), but it has not been evaluated specifically in patients
with early breast cancer. Furthermore, the value of the HAD
scale as a predictive screening tool to identify those patients
at risk of developing mood disorder has not been studied.
Preoperative detection of breast cancer patients with
depression and/or anxiety and prediction of those likely to
develop such disorder post-operatively is important if
psychosocial care is to be given appropriately and effectively.
We therefore assessed the utility of the HAD scale
administered once, preoperatively, in defining patients who
either have or are likely to develop mood disorder in the year
after diagnosis. The performance of the HAD scale used in
this novel way was compared with the effectiveness of serial
HAD scale measurements in detecting concurrent disorder at
intervals during the post-operative year. Emphasis was placed
on identifying patients with mood disorder whether it be
anxiety and/or depression, rather than on the particular
nature ofmood disorder, as this can be assessed subsequently
when the patient is seen by a mental health professional.
Patients and methods
A consecutive series of women presenting to the Clinical
Oncology Unit, Guy's Hospital, with operable breast cancer
(T1,2 N0,1, MO) between April 1989 and June 1990 and who
were aged less than 70 were eligible to participate in the
study. Patients were treated according to policies in oper-
ation at Guy's during the study period. Briefly, patients with
unifocal tumours measuring less than 4 cm in diameter were
offered breast conservation therapy. Modified radical mastec-
tomy was recommended for those with larger tumours. Post-
menopausal patients normally received adjuvant tamoxifen.
Premenopausal patients with positive axillary nodes usually
received adjuvant chemotherapy.
Each patient was informed about the study and those who
agreed to participate underwent psychological assessment on
three occasions; immediately before operation and at 3 and
12 months after operation. Psychiatric symptoms experienced
over the previous month were elicited at each assessment
using a shortened version of the Present State Examination
(PSE) (Wing et al., 1974). This is a standardised semistruc-
tured interview, which was conducted by a research
psychologist (SRJ) who was trained in the use of the PSE.
Ratings of psychiatric symptoms were discussed at consensus
meetings held between PSE trained raters at Guy's Hospital.
Diagnoses of anxiety and/or depression were derived using
the Bedford College Criteria (Finlay-Jones et al., 1980).
These criteria enable patients to be categorised as normal,
borderline cases or full cases of anxiety and/or depression. A
full case corresponds to a level of severity of psychiatric
disorder that would be likely to be seen in a psychiatric
outpatient clinic. Patients found to be full cases and about
whom the research psychologist was clinically concerned
were referred to the Clinical Oncology Unit liaison psychiatry
service. In addition any member of the clinical team was able
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to refer a patient to the psychiatrist if he/she considered this
clinically appropriate.
Patients also completed the HAD scale at each assessment.
The HAD scale was developed specifically for use in patients
with physical disease and excludes somatic symptoms that
could be due either to mood disturbance or physical illness
and its treatment. The questionnaire enquires about 14 symp-
toms of mood disturbance over the preceding week. It is
made up of seven items about anxiety and seven items about
depression. Each item is rated on a scale of 0-3 ranging
from 'not at all' to 'very much'. This gives a maximum score
of 42. The HAD scale is quick and easy to administer,
complete and score. It usually takes a few minutes for
patients to fill in and scoring takes approximately the same
time.
Analysis
The sensitivity and specificity of the HAD scale total score
was calculated for all possible threshold scores. This was
done by looking at:
(1) The preoperative HAD scale total score in relation to
mood disorder at any of the three time points (i.e. in
detecting preoperative disorder and in predicting
disorder at 3 and 12 months).
(2) The HAD scale total score in relation to concurrent
mood disorder at all three time points.
Sentitivity represents the proportion of correctly identified
cases (number of true positives/number of true positives plus
the number offalse negatives). Specificity is the proportion of
correctly identified non-cases (number of true negatives/
number of true negatives plus number of false positives) and
hence the false-positive rate is 1 - specificity.
Receiver operating characteristic (ROC) curves (Murphy et
al., 1987) were obtained by plotting sensitivity against
(1 - specificity) for each possible threshold score looking at:
(1)
(2)
The preoperative HAD scale total score in relation to
mood disorder at any of the three time points.
The HAD scale total score in relation to concurrent
psychiatric disorder.
The ROC curve shows the discriminating power of the
HAD scale between full/borderline cases and non-cases at
every possible threshold. Examination of the ROC curve
allows a decision to be made about the optimum threshold
for identifying psychiatric disorder. This was chosen as the
score which minimises errors, i.e. the sum of the false
positives and false negatives.
The positive predictive value was calculated for each
optimum threshold. This gives the proportion of high scorers
who are true cases (true positives/true positives plus false
positives).
Results
Cohort characteristics
Ninety-one (89%) of 102 consecutive patients who fulfilled
the selection criteria were interviewed at all three assessment
times. None of the patients invited to participate declined the
first interview, seven declined the second interview and four
declined the third interview. The HAD scale was completed
by 90 of the 91 patients at all three assessments. One of the
91 patients completed the HAD scale at the first two assess-
ments only. The median age was 56 years (range 24-69).
Social class was measured according to the Registrar
General's 5-fold classification. Sixty-four (70%) patients were
either married or co-habiting, whilst four (4%) were single,
eight (9%) were divorced and 15 (17%) were widowed. Six
(7%) were in social class 1, with 12 (13%), 58 (64%), six
(7%) and nine (10%) in classes 2, 3, 4 and 5 respectively. Six
patients were offered specific psychological management, to
be undertaken by the unit liaison psychiatrist during the
study period. Three declined the offer and three experienced
a clinically significant reduction in their levels of anxiety
and/or depression following intervention.
Inter-rater reliability
Checks of inter-rater reliability were performed on a random
sample of 30% of the tape-recorded interviews. Percentage
concordance for individual items within the PSE ranged from
70-100% and for whether patients were normal, borderline
cases or full cases from 80-100%.
Prevalence ofmood disorder
Preoperative levels of mood disorder assessed by PSE were
high, 37/91 (41%) being full or borderline cases ofdepression
and/or anxiety. This declined to 29% at 3 months and 25%
at 12 months post-operatively. Fifteen (17%) of the women
were full or borderline cases at the preoperative assessment
only, 22 (24%) had this level of mood disorder both
preoperatively and post-operatively (i.e. at 3 months, 12
months or both). Thirteen (14%) developed full or borderline
case level anxiety and/or depression post-operatively. Fifteen
(17%) of the women were full cases preoperatively; seven
(8%) at 3 months and one (1%) at 12 months. A total of 20
(22%) patients were classified as full cases at one or more
assessments. A further 30 (33%) patients had borderline
anxiety and/or depression on one or more occasions but were
never full cases. The remaining 41 (45%) patients had no
significant anxiety or depression at any of the three assess-
ments.
Whilst the prevalence of mood disorder overall decreased
progressively over the study period, the patterns of anxiety
and depression differed substantially. Eighteen of the 34
patients (53%) who were anxious preoperatively had
significant levels of anxiety either at 3 months or 12 months
post-operatively, or both. Onset of anxiety post-operatively
was unusual in patients who had not had clinically significant
levels of anxiety preoperatively, occurring in only six cases
(four of whom were either also depressed post-operatively or
had been preoperatively). In contrast, only five of the 20
(25%) patients who were depressed preoperatively continued
to be depressed post-operatively, but 15 patients developed a
depression for the first time post-operatively (seven of whom
had either concomitant or preceding anxiety).
Mood disorder was to an extent associated with age.
Twenty out of 30 (67%) of patients aged less than 50 were
borderline or full cases at any time point, compared with
30/61 (49%) patients aged >50 (P = 0.1). Twelve out of 30
(40%) patients aged less than 50 were full cases, while 8/61
(13%) aged >50 were full cases (P = 0.006).
Performance ofHAD scale total score
The potential of the preoperative HAD scale total score to
identify patients who experienced mood disorder (full and
borderline cases) at any time in the year after diagnosis was
examined. This involved assessing the ability of the
preoperative HAD scale score to detect current mood
disorder and to predict disorder at 3 and 12 months post-
operatively. Adopting this approach the ROC curve demon-
strated that the optimum threshold was 11 for the HAD scale
total score. Using this threshold, 31/37 (84%) patients who
were borderline or full cases of anxiety or depression
preoperatively were correctly identified, with a false-positive
rate of 9/54 (17%). In addition, 19/26 (73%) patients with
mood disorder at 3 months and 19 of 23 (83%) patients with
mood disorder at 12 months had a preoperative HAD scale
total score > 11. Four out of 13 (31%) patients who
developed mood disorder for the first time either at the 3
month or 12 month assessment had a preoperative HAD
scale total score > 11. Using this cut-off overall, however, 35
out of the 50 women who had mood disorder (full and
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borderline cases) at some point in the year after diagnosis
were correctly identified (sensitivity = 70%). Five out of 41
women who never experienced mood disorder were incor-
rectly identified (false-positive rate = 12%). Thirty-five out of
40 of those scoring > 11 were true full or borderline cases
(positive predictive value = 88%). The preoperative HAD
scale total score was particularly sensitive to full cases, iden-
tifying 18/20 (90%) of such patients.
We examined whether the use of serial HAD scale
measurements (at 0, 3 and 12 months) to detect concurrent
mood disorder could improve on the identification rate des-
cribed above, using a single preoperative assessment (both
for detection and prediction). First we applied a uniform
cut-off of HAD scale total score > 11 at each of the three
time points. Using this method 31 patients were identified
correctly preoperatively (see above). In addition one patient
with late onset mood disorder was identified at 3 months.
Thus, in total, 32 of the 50 patients who had mood disorder
at one or more time points were identified using this
approach (sensitivity = 64%).
A further analysis of the utility of serial HAD scale
measurements for the detection of concurrent mood disorder
was undertaken using optimum cut-off levels derived from
ROC curve analyses for each time point. At 3 months the
optimum total HAD scale score was five (sensitivity = 77%;
specificity = 52%; positive predictive value = 38%). The
optimum total HAD scale score at 12 months was six (sen-
sitivity = 77%; specificity = 66%; positive predictive value =
40%). These cut-off points are, of course, well below those
usually applied using the HAD scale. Applying these
optimum cut-offs to detect late-onset mood disorder, seven
patients who developed anxiety or depression at 3 months
were identified and four patients who developed mood
disorder at 12 months were identified. Combining the use of
preoperative HAD scale total score > 11 to identify cases at
that time point with the use of the HAD scale total scores
using optimum cut-offs at 3 and 12 months, 42/50 cases were
identified. However, using this approach, 29 out of 41 who
never had mood disorder were incorrectly identified (false
positive = 71%).
Effect ofage on performance ofpreoperative HAD scale total
score
Preoperative HAD scale total scores and age were highly
significantly inter-related. Twenty-two of the 30 (73%)
patients aged less than 50 years had preoperative HAD scale
total scores > 11, compared with 18 of 61 (30%) of patients
above this age (P = 0.0001). The potential ofthe preoperative
HAD scale total score to identify psychiatric disorder in the
year after diagnosis was influenced by age.
A HAD scale total score measured preoperatively provided
an effective indication ofmood disorder occurring at the time
or at 3 and 12 months post-operatively in patients aged less
than 50 (Figure 1). Eighteen of the 22 patients aged less than
50 years who had preoperative total HAD scale score > 11
experienced mood disorder at some point in the year after
diagnosis (positive predictive value = 82%). A preoperative
HAD scale score >,11 correctly identified 18 of the 20
patients aged less than 50 years who had mood disorder (full
or borderline cases) at any time point during the study
(sensitivity = 90%). The remaining two patients had border-
line depression at one assessment point only. This threshold
score correctly identified all 12 patients aged less than 50
years who were full cases of anxiety or depression at any
time point (sensitivity = 100%). Four out of ten patients who
never experienced mood disorder were incorrectly classified
(false-positive rate = 40%).
Amongst older patients a different pattern was observed.
Seventeen out of 18 patients older than 50 who had a
preoperative total HAD scale score > 11 experienced mood
disorder at some point in the year after diagnosis (positive
predictive value = 94%). However, only 17/30 patients in this
age group who experienced mood disorder were correctly
identified by HAD scale total score > 11 (sensitivity = 57%).
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Figure 1 Distribution of preoperative HAD scale total score
according to experience of mood disorder in the year after diag-
nosis. 0, normal; +, borderline; *, full cases. HAD scale total
score of 11 is the cut-off point.
Thirty of 31 patients who had no mood disorder during the
study period had total HAD scale scores of <11 (false-
positive rate = 3%). Lowering the cut-off for the total HAD
score improved sensitivity only slightly, but increased the
false-positive rate substantially.
The low sensitivity of the preoperative total HAD scale
score >,11 in the older group was mainly in relation to
borderline cases. Six out of eight patients older than 50 who
were full cases were correctly identified (sensitivity = 75%).
Discussion
The prevalence of mood disorder experienced at one or more
assessment points in the first year after diagnosis of operable
breast cancer in this study is high (22% of patients were full
cases and 33% were borderline cases at some point). The
point prevalence of mood disorder at each of the three
assessment points (41% preoperatively, 29% at 3 months and
25% at 12 months post-operatively) is similar to those
reported in other studies, despite the use of somewhat
different criteria to define psychiatric illness (Dean, 1987;
Fallowfield et al., 1990). Psychiatric interventions provided
during the study by either the unit liaison psychiatrist or
general practitioner are therefore unlikely to have affected
significantly the prevalence of mood disorder reported in this
study. In any case, only a very small number of patients
received treatment from the unit psychiatrist during the study
period. Details ofinterventions initiated or given by a general
practitioner were not sought in this study.
The performance of a single HAD scale total score
measured preoperatively in identifying mood disorder occur-
ring at any time in the year after diagnosis was judged to be
superior to other approaches using the HAD scale to detect
concurrent mood disorder at repeated intervals throughout
the year. Administering the HAD scale to identify all cases
preoperatively in combination with the HAD scale at 3 and
12 months using optimum cut-offs derived for ROC curve
analysis to detect late-onset cases correctly identified more of
the women who were anxious or depressed. However, the
high proportion of well women who were incorrectly
identified, together with the need to administer the HAD
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scale on repeated occasions limits the practical utility of this
approach in a clinical setting. Similarly the conventional
method of using the HAD scale only to detect already exist-
ing disorder yields a high false-positive rate, involves
repeated administration and lacks the advantage of being
able to identify those at risk. The effectiveness of single HAD
scale total score in identifying mood disorder in the year
after diagnosis lies mainly in its ability to detect early tran-
sient mood disorder (i.e. those women who were cases at the
preoperative assessment only) and in its ability to detect
women whose mood disorder developed early and was sus-
tained (i.e. those with mood disorder both preoperatively and
post-operatively).
Among patients aged less than 50, a single HAD scale
total score measured preoperatively was an effective indicator
of both severe and borderline mood disorder occurring at the
time it was performed or during the following year. The
findings of this study suggest a simple management policy of
administering the HAD scale preoperatively and applying a
cut-off of 11 to the total score to identify all younger patients
who have or are likely to develop severe mood disorder and
90% of those who are at risk of less severe disorder. From
our results 73% of women aged less than 50 will be defined
as being at risk. These patients should be interviewed by a
specialist nurse trained to elicit psychiatric symptoms using a
structured interview. In our series 17 of 22 (77%) women so
identified had preoperative mood disorder and these women
should be offered appropriate psychological care. Among the
remaining five women, one subsequently developed psychiat-
ric disorder. We would therefore recommend that women
with a preoperative total HAD scale score > 11 but who are
not anxious or depressed at interview (the false positives)
should be considered at risk. They should be reassessed by
the nurse specialist at least once post-operatively (possibly at
3 months).
Among patients over 50 years, a preoperative total HAD
scale score was a highly specific screening tool. It was sen-
sitive for the identification of severe mood disorder but not
borderline mood disorder. Slightly less than half of older
women who experienced mood disorder according to inter-
view assessment were not high scorers on the HAD scale.
This suggests that older women tended not to disclose their
psychosocial distress on self-report measures. Whatever the
reason, all older patients require regular interview assessment
throughout the year after diagnosis (for example 3 and 12
months), if borderline and full case mood disorder is to be
diagnosed.
We now routinely record patients' total HAD scale scores
shortly after diagnosis. This can alert clinicians to patients
who have or are at high risk of developing mood disorder.
However clinicians should not be falsely reassured by low
scores in women over 50 years. Patients are also invited to
make contact with the specialist nurse should they develop
psychological difficulties at any time.
Women who are found to be full cases of anxiety or
depression at interview with the specialist nurse are likely to
benefit from structured psychological therapy (e.g. Greer et
al., 1992) either alone or in conjunction with psychotropic
medication (Costa et al., 1985). Therefore if they are
motivated to receive psychological help this could be initiated
by an appropriately trained specialist nurse. Alternatively the
nurse could refer them to a psychiatrist or clinical
psychologist or liaise with the general practitioner. Women
with borderline levels of anxiety and depression are likely to
have more diverse needs. Some may benefit from a formal
psychological therapy, others from the specialist nurse
teaching them self-help techniques for managing anxiety
(Snaith, 1992). It is likely that a considerable proportion
experiencing borderline mood disorder preoperatively will
require little more than honest, but compassionate explana-
tion and reassurance about their disease and its management
from the doctors and nurses responsible for their care.
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